Cochlear Share Price and Company Fundamentals

5.640 (2.441%)
52 week
184.62 - 236.69

Last traded: Yesterday at 5:10 AM

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Primary activities Manufacture and sale of Cochlear implant systems.
Industry / Sector Medical Devices / Healthcare
Full time employees 4500
Mailing address 1 University Avenue Macquarie University Sydney NSW 2109 Australia
Phone / Fax 61 2 9428 6555 / 61 2 9428 6353


More: Cochlear Dividend history, yield and payout ratio

Dividend yield


Dividend amount


Payout ratio


Cochlear paid $1.45 dividend and the ex-dividend date was 21 Mar 2023.The dividend payout ratio is 75.47%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.COH dividend payout ratio is between 70-90%. The lower dividend payout ratio is preferrable since it provides company margin to grow the dividends in future.

COH's forward dividend amount is $3.1 and the forward dividend yield is 1.31%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Apr 2023, following are the company executives and directors listed on Cochlear.

Name Title Age Total Pay
Mr. Diggory William Howitt BE (Hons), MBA CEO, MD, Pres & Exec. Director 55 3.88M
Mr. Stuart Sayers Chief Financial Officer 1.47M
Mr. Jan Janssen MSc Elec Eng Chief Technology Officer 56 1.63M
Mr. Anthony Bishop Pres of Asia Pacific & Latin America 1.22M
Ms. Lisa Aubert Pres of North America 973k
Mr. Richard Brook MBA Pres of EMEA 1.82M
Ms. Karen O'Driscoll Chief Information Officer
Ms. Kristina Devon VP of Investor Relations
Ms. Jennifer Stevenson VP of Corp. Communications & Brand
Mr. Dean Phizacklea Sr. VP of Global Strategic Marketing

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Cochlear is and its enterprise value is .

The COH's stocks Beta value is 0.45 making it 55% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Cochlear (COH)

Cochlear (ASX:COH) Frequently Asked Questions

1. What is Cochlear's Stock Symbol?

Cochlear trades on ASX under the ticker symbol "COH".

2. What is Cochlear's stock price today?

One share of COH stock can currently be purchased for approximately $236.69.

3. How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue Macquarie University Sydney NSW 2109 Australia. The company can be reached via phone at 61 2 9428 6555.

4. What is Cochlear's official website?

The official website of Cochlear is

5. Which share registry manages Cochlear's stock?